イロペリドン薬品のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Iloperidone Drugs Market Insights and Forecast to 2027

• レポートコード：QY2112C03865 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はイロペリドン薬品の世界市場の現状について調査・分析し、2027年までの市場を予測しました。イロペリドン薬品の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ブランド医薬品、ジェネリック医薬品）、用途別市場規模（統合失調症、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・イロペリドン薬品の世界市場概要 ・メーカー別の競争状況、市場シェア ・イロペリドン薬品の種類別市場規模：ブランド医薬品、ジェネリック医薬品 ・イロペリドン薬品の用途別市場規模：統合失調症、その他 ・北米のイロペリドン薬品市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのイロペリドン薬品市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのイロペリドン薬品市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のイロペリドン薬品市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのイロペリドン薬品市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Vanda、Taro Pharmaceutical、Inventia、Alembic Pharmaceuticals、CSPC、Hansoh Pharma ・イロペリドン薬品のバリューチェーン・販売チャネル分析 ・イロペリドン薬品の世界市場動向

Iloperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions).

Market Analysis and Insights: Global Iloperidone Drugs Market
The global Iloperidone Drugs market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Iloperidone Drugs Scope and Segment
Iloperidone Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Iloperidone Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Brand Drugs
Generic Drugs

Segment by Application
Schizophrenia
Others

By Company
Vanda
Taro Pharmaceutical
Inventia
Alembic Pharmaceuticals
CSPC
Hansoh Pharma

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Iloperidone Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Iloperidone Drugs Market Size Growth Rate by Type
1.2.2 Brand Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Iloperidone Drugs Market Size Growth Rate by Application
1.3.2 Schizophrenia
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Iloperidone Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Iloperidone Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Iloperidone Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Iloperidone Drugs Regions by Sales
2.4.1 Global Top Iloperidone Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Iloperidone Drugs Regions by Sales (2022-2027)
2.5 Global Top Iloperidone Drugs Regions by Revenue
2.5.1 Global Top Iloperidone Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Iloperidone Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Iloperidone Drugs Sales by Manufacturers
3.1.1 Global Top Iloperidone Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Iloperidone Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Iloperidone Drugs Sales in 2020
3.2 Global Iloperidone Drugs Revenue by Manufacturers
3.2.1 Global Top Iloperidone Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Iloperidone Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Iloperidone Drugs Revenue in 2020
3.3 Global Iloperidone Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Iloperidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Iloperidone Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Iloperidone Drugs Sales by Type
4.1.1 Global Iloperidone Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Iloperidone Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Iloperidone Drugs Sales Market Share by Type (2016-2027)
4.2 Global Iloperidone Drugs Revenue by Type
4.2.1 Global Iloperidone Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Iloperidone Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Iloperidone Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Iloperidone Drugs Price by Type
4.3.1 Global Iloperidone Drugs Price by Type (2016-2021)
4.3.2 Global Iloperidone Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Iloperidone Drugs Sales by Application
5.1.1 Global Iloperidone Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Iloperidone Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Iloperidone Drugs Sales Market Share by Application (2016-2027)
5.2 Global Iloperidone Drugs Revenue by Application
5.2.1 Global Iloperidone Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Iloperidone Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Iloperidone Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Iloperidone Drugs Price by Application
5.3.1 Global Iloperidone Drugs Price by Application (2016-2021)
5.3.2 Global Iloperidone Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Iloperidone Drugs Market Size by Type
6.1.1 North America Iloperidone Drugs Sales by Type (2016-2027)
6.1.2 North America Iloperidone Drugs Revenue by Type (2016-2027)
6.2 North America Iloperidone Drugs Market Size by Application
6.2.1 North America Iloperidone Drugs Sales by Application (2016-2027)
6.2.2 North America Iloperidone Drugs Revenue by Application (2016-2027)
6.3 North America Iloperidone Drugs Market Size by Country
6.3.1 North America Iloperidone Drugs Sales by Country (2016-2027)
6.3.2 North America Iloperidone Drugs Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Iloperidone Drugs Market Size by Type
7.1.1 Europe Iloperidone Drugs Sales by Type (2016-2027)
7.1.2 Europe Iloperidone Drugs Revenue by Type (2016-2027)
7.2 Europe Iloperidone Drugs Market Size by Application
7.2.1 Europe Iloperidone Drugs Sales by Application (2016-2027)
7.2.2 Europe Iloperidone Drugs Revenue by Application (2016-2027)
7.3 Europe Iloperidone Drugs Market Size by Country
7.3.1 Europe Iloperidone Drugs Sales by Country (2016-2027)
7.3.2 Europe Iloperidone Drugs Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Iloperidone Drugs Market Size by Type
8.1.1 Asia Pacific Iloperidone Drugs Sales by Type (2016-2027)
8.1.2 Asia Pacific Iloperidone Drugs Revenue by Type (2016-2027)
8.2 Asia Pacific Iloperidone Drugs Market Size by Application
8.2.1 Asia Pacific Iloperidone Drugs Sales by Application (2016-2027)
8.2.2 Asia Pacific Iloperidone Drugs Revenue by Application (2016-2027)
8.3 Asia Pacific Iloperidone Drugs Market Size by Region
8.3.1 Asia Pacific Iloperidone Drugs Sales by Region (2016-2027)
8.3.2 Asia Pacific Iloperidone Drugs Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Iloperidone Drugs Market Size by Type
9.1.1 Latin America Iloperidone Drugs Sales by Type (2016-2027)
9.1.2 Latin America Iloperidone Drugs Revenue by Type (2016-2027)
9.2 Latin America Iloperidone Drugs Market Size by Application
9.2.1 Latin America Iloperidone Drugs Sales by Application (2016-2027)
9.2.2 Latin America Iloperidone Drugs Revenue by Application (2016-2027)
9.3 Latin America Iloperidone Drugs Market Size by Country
9.3.1 Latin America Iloperidone Drugs Sales by Country (2016-2027)
9.3.2 Latin America Iloperidone Drugs Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Iloperidone Drugs Market Size by Type
10.1.1 Middle East and Africa Iloperidone Drugs Sales by Type (2016-2027)
10.1.2 Middle East and Africa Iloperidone Drugs Revenue by Type (2016-2027)
10.2 Middle East and Africa Iloperidone Drugs Market Size by Application
10.2.1 Middle East and Africa Iloperidone Drugs Sales by Application (2016-2027)
10.2.2 Middle East and Africa Iloperidone Drugs Revenue by Application (2016-2027)
10.3 Middle East and Africa Iloperidone Drugs Market Size by Country
10.3.1 Middle East and Africa Iloperidone Drugs Sales by Country (2016-2027)
10.3.2 Middle East and Africa Iloperidone Drugs Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Vanda
11.1.1 Vanda Corporation Information
11.1.2 Vanda Overview
11.1.3 Vanda Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Vanda Iloperidone Drugs Product Description
11.1.5 Vanda Recent Developments
11.2 Taro Pharmaceutical
11.2.1 Taro Pharmaceutical Corporation Information
11.2.2 Taro Pharmaceutical Overview
11.2.3 Taro Pharmaceutical Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Taro Pharmaceutical Iloperidone Drugs Product Description
11.2.5 Taro Pharmaceutical Recent Developments
11.3 Inventia
11.3.1 Inventia Corporation Information
11.3.2 Inventia Overview
11.3.3 Inventia Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Inventia Iloperidone Drugs Product Description
11.3.5 Inventia Recent Developments
11.4 Alembic Pharmaceuticals
11.4.1 Alembic Pharmaceuticals Corporation Information
11.4.2 Alembic Pharmaceuticals Overview
11.4.3 Alembic Pharmaceuticals Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Alembic Pharmaceuticals Iloperidone Drugs Product Description
11.4.5 Alembic Pharmaceuticals Recent Developments
11.5 CSPC
11.5.1 CSPC Corporation Information
11.5.2 CSPC Overview
11.5.3 CSPC Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 CSPC Iloperidone Drugs Product Description
11.5.5 CSPC Recent Developments
11.6 Hansoh Pharma
11.6.1 Hansoh Pharma Corporation Information
11.6.2 Hansoh Pharma Overview
11.6.3 Hansoh Pharma Iloperidone Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Hansoh Pharma Iloperidone Drugs Product Description
11.6.5 Hansoh Pharma Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Iloperidone Drugs Value Chain Analysis
12.2 Iloperidone Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Iloperidone Drugs Production Mode & Process
12.4 Iloperidone Drugs Sales and Marketing
12.4.1 Iloperidone Drugs Sales Channels
12.4.2 Iloperidone Drugs Distributors
12.5 Iloperidone Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Iloperidone Drugs Industry Trends
13.2 Iloperidone Drugs Market Drivers
13.3 Iloperidone Drugs Market Challenges
13.4 Iloperidone Drugs Market Restraints

14 Key Findings in The Global Iloperidone Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Iloperidone Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Brand Drugs
Table 3. Major Manufacturers of Generic Drugs
Table 4. Global Iloperidone Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Iloperidone Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Iloperidone Drugs Sales by Region (2016-2021) & (K Units)
Table 7. Global Iloperidone Drugs Sales Market Share by Region (2016-2021)
Table 8. Global Iloperidone Drugs Sales by Region (2022-2027) & (K Units)
Table 9. Global Iloperidone Drugs Sales Market Share by Region (2022-2027)
Table 10. Global Iloperidone Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Iloperidone Drugs Revenue Market Share by Region (2016-2021)
Table 12. Global Iloperidone Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Iloperidone Drugs Revenue Market Share by Region (2022-2027)
Table 14. Global Iloperidone Drugs Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Iloperidone Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Global Iloperidone Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Iloperidone Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Iloperidone Drugs Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Iloperidone Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Iloperidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloperidone Drugs as of 2020)
Table 21. Iloperidone Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Iloperidone Drugs Product Offered
Table 23. Date of Manufacturers Enter into Iloperidone Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 26. Global Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 27. Global Iloperidone Drugs Sales Share by Type (2016-2021)
Table 28. Global Iloperidone Drugs Sales Share by Type (2022-2027)
Table 29. Global Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Iloperidone Drugs Revenue Share by Type (2016-2021)
Table 32. Global Iloperidone Drugs Revenue Share by Type (2022-2027)
Table 33. Iloperidone Drugs Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Iloperidone Drugs Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Global Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 37. Global Iloperidone Drugs Sales Share by Application (2016-2021)
Table 38. Global Iloperidone Drugs Sales Share by Application (2022-2027)
Table 39. Global Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Iloperidone Drugs Revenue Share by Application (2016-2021)
Table 42. Global Iloperidone Drugs Revenue Share by Application (2022-2027)
Table 43. Iloperidone Drugs Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Iloperidone Drugs Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 46. North America Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 47. North America Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 50. North America Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 51. North America Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Iloperidone Drugs Sales by Country (2016-2021) & (K Units)
Table 54. North America Iloperidone Drugs Sales by Country (2022-2027) & (K Units)
Table 55. North America Iloperidone Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Iloperidone Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Europe Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 59. Europe Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 62. Europe Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 63. Europe Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Iloperidone Drugs Sales by Country (2016-2021) & (K Units)
Table 66. Europe Iloperidone Drugs Sales by Country (2022-2027) & (K Units)
Table 67. Europe Iloperidone Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Iloperidone Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Iloperidone Drugs Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Iloperidone Drugs Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Iloperidone Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Iloperidone Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Iloperidone Drugs Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Iloperidone Drugs Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Iloperidone Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Iloperidone Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Iloperidone Drugs Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Iloperidone Drugs Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Iloperidone Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Iloperidone Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Iloperidone Drugs Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Iloperidone Drugs Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Iloperidone Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Iloperidone Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Iloperidone Drugs Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Iloperidone Drugs Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Iloperidone Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Iloperidone Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 105. Vanda Corporation Information
Table 106. Vanda Description and Major Businesses
Table 107. Vanda Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Vanda Iloperidone Drugs Product
Table 109. Vanda Recent Developments
Table 110. Taro Pharmaceutical Corporation Information
Table 111. Taro Pharmaceutical Description and Major Businesses
Table 112. Taro Pharmaceutical Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Taro Pharmaceutical Iloperidone Drugs Product
Table 114. Taro Pharmaceutical Recent Developments
Table 115. Inventia Corporation Information
Table 116. Inventia Description and Major Businesses
Table 117. Inventia Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Inventia Iloperidone Drugs Product
Table 119. Inventia Recent Developments
Table 120. Alembic Pharmaceuticals Corporation Information
Table 121. Alembic Pharmaceuticals Description and Major Businesses
Table 122. Alembic Pharmaceuticals Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Alembic Pharmaceuticals Iloperidone Drugs Product
Table 124. Alembic Pharmaceuticals Recent Developments
Table 125. CSPC Corporation Information
Table 126. CSPC Description and Major Businesses
Table 127. CSPC Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. CSPC Iloperidone Drugs Product
Table 129. CSPC Recent Developments
Table 130. Hansoh Pharma Corporation Information
Table 131. Hansoh Pharma Description and Major Businesses
Table 132. Hansoh Pharma Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Hansoh Pharma Iloperidone Drugs Product
Table 134. Hansoh Pharma Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Iloperidone Drugs Distributors List
Table 138. Iloperidone Drugs Customers List
Table 139. Iloperidone Drugs Market Trends
Table 140. Iloperidone Drugs Market Drivers
Table 141. Iloperidone Drugs Market Challenges
Table 142. Iloperidone Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Iloperidone Drugs Product Picture
Figure 2. Global Iloperidone Drugs Market Share by Type in 2020 & 2027
Figure 3. Brand Drugs Product Picture
Figure 4. Generic Drugs Product Picture
Figure 5. Global Iloperidone Drugs Market Share by Application in 2020 & 2027
Figure 6. Schizophrenia
Figure 7. Others
Figure 8. Iloperidone Drugs Report Years Considered
Figure 9. Global Iloperidone Drugs Sales 2016-2027 (K Units)
Figure 10. Global Iloperidone Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Iloperidone Drugs Revenue 2016-2027 (US$ Million)
Figure 12. Global Iloperidone Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Iloperidone Drugs Sales Market Share by Region (2016-2021)
Figure 14. Global Iloperidone Drugs Sales Market Share by Region (2022-2027)
Figure 15. North America Iloperidone Drugs Sales YoY (2016-2027) & (K Units)
Figure 16. North America Iloperidone Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Iloperidone Drugs Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Iloperidone Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Iloperidone Drugs Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Iloperidone Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Iloperidone Drugs Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Iloperidone Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Iloperidone Drugs Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Iloperidone Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Iloperidone Drugs Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Iloperidone Drugs Revenue in 2020
Figure 27. Iloperidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 29. Global Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 30. Global Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 31. Global Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 32. North America Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 33. North America Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 34. North America Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 35. North America Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 36. North America Iloperidone Drugs Sales Share by Country (2016-2027)
Figure 37. North America Iloperidone Drugs Revenue Share by Country (2016-2027)
Figure 38. United States Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 41. Europe Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 42. Europe Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 43. Europe Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 44. Europe Iloperidone Drugs Sales Share by Country (2016-2027)
Figure 45. Europe Iloperidone Drugs Revenue Share by Country (2016-2027)
Figure 46. Germany Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 47. France Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Iloperidone Drugs Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Iloperidone Drugs Revenue Share by Region (2016-2027)
Figure 57. China Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 60. India Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 67. Latin America Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 69. Latin America Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Iloperidone Drugs Sales Share by Country (2016-2027)
Figure 71. Latin America Iloperidone Drugs Revenue Share by Country (2016-2027)
Figure 72. Mexico Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 75. Middle East and Africa Iloperidone Drugs Sales Market Share by Type (2016-2027)
Figure 76. Middle East and Africa Iloperidone Drugs Revenue Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Iloperidone Drugs Sales Market Share by Application (2016-2027)
Figure 78. Middle East and Africa Iloperidone Drugs Revenue Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Iloperidone Drugs Sales Share by Country (2016-2027)
Figure 80. Middle East and Africa Iloperidone Drugs Revenue Share by Country (2016-2027)
Figure 81. Turkey Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 82. Saudi Arabia Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 83. UAE Iloperidone Drugs Revenue (2016-2027) & (US$ Million)
Figure 84. Iloperidone Drugs Value Chain
Figure 85. Iloperidone Drugs Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

---